A randomized, controlled, double-blinded clinical trial evaluating the effect of the administration of a Maltodextrin solution on cardiac function in patients presenting for coronary artery bypass grafting surgery with a reduced left ventricular ejection fraction.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Intraoperative three-dimensional left ventricular ejection fraction (3-D LVEF)
Timeframe: After induction of anesthesia, prior to the start of surgery, and at the conclusion of surgery, just after chest closure